Skip to main content
OpenTrials
Completed

NCT Number: NCT06915103

A Case Report of NMDAR Encephalopathy

This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspected Anti-NMDA Encephalitis

Exclusion criteria

  • Inability to consent

Treatment and study plan

Magnetic Resonance Imaging (MRI)

Diagnostic Test

A pelvic MRI with and without contrast was performed for evaluation of the ovary.

Salpingo-Oophorectomy

Procedure

Salpingo-oophorectomy procedure was performed on the left ovary.

Primary outcomes

  1. Anti-NMDA Encephalitis

    Time frame: 1 week

    Diagnosis of Anti-NMDA Encephalitis based on pelvic MRI

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Apr 8, 2025
Registry last updated
Apr 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.